Related Experiment Video
Updated: Aug 7, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
The use of controlled-release morphine sulfate (MS Contin) in Queensland 1990-1993
1Environmental Health Branch, Queensland Health, Brisbane.
Objectives:
To investigate the use of controlled-release morphine sulfate (MS Contin, Pharmacia) in Queensland, 1990-1993.
Patients And Design:
Records of 434 patients notified to the Drugs of Dependence Unit (DDU) for prolonged use of MS Contin (as at 16 August 1993) were analysed, the information was verified, and the patients' diagnoses were coded (ICD-9). Estimates of daily drug consumption were calculated from computerised prescription data.
Results:
Controlled-release morphine sulfate was being used for indications other than its licensed indication "chronic severe pain of cancer": 39.9% of the patients received the drug for non-malignant conditions. The dose escalation for patients with non-malignant conditions was significantly less than that of the patients with malignant conditions (P = 0.002).
Conclusions:
Despite controversy about the use of controlled-release morphine sulfate for chronic pain of non-malignant origin, its use is widespread.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Oral Drug Delivery Systems: Continuous-Release Systems

